Portfolio company
Accretion Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops a live-cell single-molecule imaging platform for pharmaceutical and biotechnology partners to observe biological processes in neurons for drug discovery.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Eikon Therapeutics
This biopharmaceutical company develops small molecule medicines for patients with cancer and other serious diseases using a live-cell imaging drug discovery platform.
Micrographia Bio
This company develops AI-driven microscopy and spatial proteomics platforms to help drug developers and researchers visualise molecular interactions and identify therapeutic targets.
Lightcast Bio
This company develops a microfluidic platform for single-cell functional analysis for pharmaceutical companies and academic research institutions.
Cellanome
This company develops a multi-omics platform that integrates imaging and sequencing for single-cell analysis to serve biotechnology researchers and drug developers.
Oscillution
This company provides in vitro human brain cell models and testing platforms to pharmaceutical and biotech firms for drug discovery and safety assessment.
Inscopix
This company develops miniature brain imaging systems and software for neuroscience researchers in academia and industry to study neural circuits in freely behaving animals.
Recursion Pharma
This company provides a technology platform for drug discovery and development to pharmaceutical partners and develops internal therapeutic candidates for patients with unmet medical needs.
Biodock
This company provides a cloud-based artificial intelligence platform for microscopy image analysis, serving pharmaceutical companies and academic research institutions.
